RxDoctor Payments DataLook up a doctor →

Mark Carlson, MD

Internal Medicine · Sioux City, IANPI 1609837368

Payments from drug & device makers

$173,868in general payments, 2019–2025

Across 643 payments — averaging $270.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$166K
  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$536
  • Bayer$499
  • Esperion Therapeutics, Inc.$499
  • plus $4K from 35 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen252$165,542
AbbVie(2 entities)13$1,623
AstraZeneca(2 entities)48$1,179
Novo Nordisk30$536
Bayer20$499
Esperion Therapeutics, Inc.53$499
Amarin Pharma, Inc.31$424
Pfizer23$385
GSK12$311
Boehringer Ingelheim20$307
Radius Health, Inc.16$297
Johnson & Johnson(2 entities)14$268
Astellas Pharma US Inc9$255
Pacira Therapeutics, Inc.9$205
Novartis13$182
Lilly USA, LLC11$165
Kowa Pharmaceuticals America, Inc.12$147
Regeneron Healthcare Solutions, Inc.7$132
Biohaven Pharmaceutical Holding Company Ltd.1$116
Sunovion Pharmaceuticals Inc.6$89
Mannkind Corporation2$67
Otsuka America Pharmaceutical, Inc.3$64
Mayne Pharma Commercial LLC6$54
Philips North America LLC3$45
Mallinckrodt Hospital Products Inc.2$45
Mylan Specialty L.p.3$41
Merck3$38
Currax Pharmaceuticals LLC3$37
Ascendis Pharma Endocrinology Inc2$35
Azurity Pharmaceuticals, Inc.2$34
Exact Sciences2$34
Inspire Medical Systems, Inc.1$34
E.r. Squibb & Sons, L.L.C.2$32
Sanofi-aventis U.S. LLC2$26
Acadia Pharmaceuticals Inc1$23
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$21
Pacira Pharmaceuticals Incorporated1$17
Arbor Pharmaceuticals, Inc.1$17
Nalpropion Pharmaceuticals LLC1$15
Ardelyx, Inc.1$14
Travere Therapeutics, Inc.1$13

How this compares

$173,868 in reported general payments places this provider in the 95th percentile of 583 internal medicine providers in Iowa.

See all internal medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$166,455
Medicare patients
175
Services billed
3,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Sioux City

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →